10/06/2026 | Press release | Distributed by Public on 10/06/2026 12:19
Lake Street Capital Markets Analyst, Frank Takkinen, initiated coverage of Envoy Medical, Inc. with a BUY rating and price target of $2.50 (COCH-$2.50). Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum.